PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
236 hedge funds and large institutions have $4.66B invested in PRA Health Sciences, Inc. in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 88 increasing their positions, 93 reducing their positions, and 28 closing their positions.
133% more funds holding in top 10
Funds holding in top 10: 3 → 7 (+4)
29% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 28
15% more capital invested
Capital invested by funds: $4.06B → $4.66B (+$602M)
3% more funds holding
Funds holding: 229 → 236 (+7)
5% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 93
67% less call options, than puts
Call options by funds: $4.59M | Put options by funds: $14.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$115M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$68M |
| 3 |
BlackRock
New York
|
+$55.8M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$19.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$18.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWNA
Marshall Wace North America
New York
|
-$62.1M |
| 2 |
Goldman Sachs
New York
|
-$58.4M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$31.9M |
| 4 |
Two Sigma Investments
New York
|
-$20.8M |
| 5 |
HHC
Hutchin Hill Capital
New York
|
-$19M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
251
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$571K | -8,750 | Closed |
|
|
PA
252
Perceptive Advisors
New York
| – | -$542K | -8,308 | Closed |
|
|
QI
253
Quotient Investors
New York
| – | -$535K | -8,200 | Closed |
|
|
BIM
254
Bogle Investment Management
Newton Lower Falls,
Massachusetts
| – | -$399K | -6,120 | Closed |
|
255
Jane Street
New York
| – | -$363K | -5,239 | Closed |
|
|
SB
256
Suntrust Banks
Atlanta,
Georgia
| – | -$274K | -4,208 | Closed |
|
|
NIT
257
NumerixS Investment Technologies
Vancouver,
British Columbia, Canada
| – | -$267K | -4,100 | Closed |
|
|
SSG
258
Summit Securities Group
New York
| – | -$267K | -4,092 | Closed |
|
|
AIM
259
Alambic Investment Management
Belvedere,
California
| – | -$228K | -3,500 | Closed |
|
|
FMA
260
FNY Managed Accounts
New York
| – | -$97K | -1,500 | Closed |
|
|
TRCT
261
Tower Research Capital (TRC)
New York
| – | -$81K | -1,242 | Closed |
|
262
Walleye Trading
New York
| – | -$60 | -914 | Closed |
|
|
CG
263
Cutler Group
San Francisco,
California
| – | -$53.3K | -769 | Closed |
|
PRAH Hedge Fund Activity: Q2 2017 in Review
236 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q2 2017, worth a combined $4.66B — up 15% from $4.06B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new PRAH positions and 28 closed out — a net gain of 8 holders — while 88 added to existing stakes and 93 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $115M. The largest seller was Marshall Wace North America, cutting an estimated $62.1M.
- 236 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q2 2017, up from 229 in Q1 2017.
- Funds reported $4.66B of PRA Health Sciences, Inc. stock for Q2 2017, up 15% quarter-over-quarter.
- 36 funds opened new PRA Health Sciences, Inc. positions in Q2 2017 and 28 closed out, a net change of +8 holders.
- The largest PRA Health Sciences, Inc. buyer in Q2 2017 was Capital Research Global Investors, an estimated $115M added.
- The largest PRA Health Sciences, Inc. seller in Q2 2017 was Marshall Wace North America, an estimated $62.1M sold.
Based on aggregated 13F filings for Q2 2017.